These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 20178687)
21. The modulation of microRNAs by type I IFN through the activation of signal transducers and activators of transcription 3 in human glioma. Ohno M; Natsume A; Kondo Y; Iwamizu H; Motomura K; Toda H; Ito M; Kato T; Wakabayashi T Mol Cancer Res; 2009 Dec; 7(12):2022-30. PubMed ID: 19934272 [TBL] [Abstract][Full Text] [Related]
22. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance. Shin YK; Yoo BC; Chang HJ; Jeon E; Hong SH; Jung MS; Lim SJ; Park JG Cancer Res; 2005 Apr; 65(8):3162-70. PubMed ID: 15833846 [TBL] [Abstract][Full Text] [Related]
23. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Papagiannakopoulos T; Shapiro A; Kosik KS Cancer Res; 2008 Oct; 68(19):8164-72. PubMed ID: 18829576 [TBL] [Abstract][Full Text] [Related]
24. The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil. Matsuoka K; Tsukuda K; Suda M; Kobayashi K; Ota T; Okita A; Watanabe K; Suzuki E; Murakami M; Doihara H; Shimizu N Int J Oncol; 2004 Jan; 24(1):217-22. PubMed ID: 14654960 [TBL] [Abstract][Full Text] [Related]
25. Synergism between a siRNA targeted to survivin and 5-FU in inhibiting MCF-7 cell proliferation in vitro. Zhang SQ; Zhang SH; Xue XH; Wang XJ; Jiang JT Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):251-4. PubMed ID: 16546719 [TBL] [Abstract][Full Text] [Related]
26. [Bcl-XL antisense oligodeoxynucleotide sensitizes human esophageal cancer cell line to 5-fluorouracil]. Zhang L; Wen HT; Wang LX; Zhang L; Zhang YH Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):173-7. PubMed ID: 16875599 [TBL] [Abstract][Full Text] [Related]
27. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Fornari F; Gramantieri L; Giovannini C; Veronese A; Ferracin M; Sabbioni S; Calin GA; Grazi GL; Croce CM; Tavolari S; Chieco P; Negrini M; Bolondi L Cancer Res; 2009 Jul; 69(14):5761-7. PubMed ID: 19584283 [TBL] [Abstract][Full Text] [Related]
28. Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols. De Angelis PM; Kravik KL; Tunheim SH; Haug T; Reichelt WH Mol Cancer; 2004 Apr; 3():11. PubMed ID: 15109396 [TBL] [Abstract][Full Text] [Related]
29. Effects of 5-fluouracil combined with sulfasalazine on human pancreatic carcinoma cell line BxPC-3 proliferation and apoptosis in vitro. Huang Z; Guo KJ; Guo RX; He SG Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):312-20. PubMed ID: 17548258 [TBL] [Abstract][Full Text] [Related]
30. 5-Fluorouracil interferes with paclitaxel cytotoxicity against human solid tumor cells. Johnson KR; Wang L; Miller MC; Willingham MC; Fan W Clin Cancer Res; 1997 Oct; 3(10):1739-45. PubMed ID: 9815558 [TBL] [Abstract][Full Text] [Related]
31. Characterized mechanism of alpha-mangostin-induced cell death: caspase-independent apoptosis with release of endonuclease-G from mitochondria and increased miR-143 expression in human colorectal cancer DLD-1 cells. Nakagawa Y; Iinuma M; Naoe T; Nozawa Y; Akao Y Bioorg Med Chem; 2007 Aug; 15(16):5620-8. PubMed ID: 17553685 [TBL] [Abstract][Full Text] [Related]
32. MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme. Li Y; Li W; Yang Y; Lu Y; He C; Hu G; Liu H; Chen J; He J; Yu H Brain Res; 2009 Aug; 1286():13-8. PubMed ID: 19559015 [TBL] [Abstract][Full Text] [Related]
33. Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment. Adamsen BL; Kravik KL; Clausen OP; De Angelis PM Int J Oncol; 2007 Dec; 31(6):1491-500. PubMed ID: 17982676 [TBL] [Abstract][Full Text] [Related]
34. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy. Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101 [TBL] [Abstract][Full Text] [Related]
36. LRRC4 inhibits glioblastoma cell proliferation, migration, and angiogenesis by downregulating pleiotropic cytokine expression and responses. Wu M; Huang C; Li X; Li X; Gan K; Chen Q; Tang Y; Tang K; Shen S; Li G J Cell Physiol; 2008 Jan; 214(1):65-74. PubMed ID: 17541939 [TBL] [Abstract][Full Text] [Related]
37. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model. You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256 [TBL] [Abstract][Full Text] [Related]
38. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas. Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532 [TBL] [Abstract][Full Text] [Related]
39. MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells. Borralho PM; Kren BT; Castro RE; da Silva IB; Steer CJ; Rodrigues CM FEBS J; 2009 Nov; 276(22):6689-700. PubMed ID: 19843160 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]